TELL town hall meeting
Part of our TELL team got together for a milestone recap and planning meeting in Buenos Aires. Multiple breakthroughs in progress as we keep pushing the digital speech biomarker agenda worldwide.
The language changes that separate normal ageing from dementia
Sometimes, dementia changes how people speak. Because it can affect the part of the brain responsible for language, it may mean those with the condition struggle to finish a sentence, replace an intended word with another one, or jumble up their words. To read the full article, click here.
As words come of age, as words come undone
The boundary between normal aging and early Alzheimer’s is rarely clear for the untrained eye. Experts rely on long cognitive batteries, expensive brain scans, and invasive biofluid markers. Yet, there’s another, simpler lens on the aging brain—one we use all day, often without thinking: the way we speak. In my recent Review, I mapped how […]
It’s not just about how much you remember (in Spanish)
Un modelo automatizado de análisis del lenguaje detecta alteraciones sutiles en la forma de narrar en personas con VIH, más allá de cuánto recuerdan. La herramienta ofrece un enfoque objetivo y escalable para mejorar el cribado y el acceso a la salud cerebral. You can read the full article, in Spanish, here. An […]
Automated analysis of verbal fluency in primary progressive aphasia (in Spanish)
Adolfo M. García and Franco J. Ferrante demonstrate that analyzing the characteristics of words produced during a verbal fluency test—rather than just their quantity—allows for better differentiation among variants of primary progressive aphasia. Automated analysis of linguistic variables provides additional diagnostic information based on a simple clinical task. You can read the full article, in […]
Digital language analysis to assess cognitive impairment in Parkinson’s disease (in Spanish)
An international study led by Franco Ferrante and Adolfo García demonstrated that automated analysis of the words produced in verbal fluency tests can predict cognitive status with high accuracy in patients with Parkinson’s disease. You can read the full article, in Spanish, here. Un estudio internacional liderado por Franco Ferrante y Adolfo García demostró que el análisis […]
Our collaboration with DAC presented at ADPD
Our joint effort with DAC to bring and adapt digital speech-based tools for cognitive assessment to underserved countries reaches ADPD 2026. We are honored to share the floor with stellar speakers at DAC’s Global Cohorts Program event!
TELL was selected by IDB Lab’s Silver Region
TELL was selected as part of Cohort 3 of Silver Region, the first multilateral fund in Latin America and the Caribbean focused on boosting the economy and improving care for people over 60. Learn more about Silver Region here.
Creative Brain Week 2026
Our CSO, Dr. Adolfo García, attended Creative Brain Week 2026 to discuss collaborative bridges from science to the clinical world.
Keynote talk at 2026 Holloway Summit
Dr. Adolfo García shared some insights on the role of speech and other digital biomarkers for FTD syndromes amidst leading experts on key topics.